Notifications
Back

TECHNOLOGY

TECHNOLOGY

Effectiveness

Effectiveness 


Based on our proprietary Euglena production technology,

our company is actively demonstrating

and verifying the biofunctional benefits of Euglena.






Euglena Powder



  • Toxicity Assessment Data: Currently under study (to be provided in a forthcoming publication)
  • Immune Function Assessment Data: Currently under study (to be provided in a forthcoming publication)


◆ Euglena

▶Anticancer Efficacy


This study was conducted by KLS Bio Co., Ltd. Using a xenograft model, female BALB/c-NU mice were administered Euglena for 4 weeks. The results showed that medium-dose (1,000 mg/kg) and high-dose (2,000 mg/kg) groups exhibited greater tumor growth inhibition compared to the low-dose group (500 mg/kg).

These findings suggest that Euglena may inhibit tumor growth in a dose-dependent manner.

▶Osteoporosis Efficacy


This study was conducted by KLS Bio Co., Ltd. Female Sprague-Dawley rats underwent ovariectomy (OVX) to induce osteoporosis, and Euglena was orally administered for 15 weeks to evaluate bone mineral density.

The results showed that the medium-dose group (1,000 mg/kg) exhibited an improvement in bone mineral density compared to the OVX control group.

These findings suggest that Euglena may provide a certain level of benefit in improving osteoporosis.

▶Hangover Relief Efficacy of Euglena Powder


Animal studies have demonstrated the hangover-relieving effects of Euglena powder. In a model where male Sprague-Dawley rats were given a single dose of alcohol, Euglena powder significantly influenced the metabolism of acetaldehyde and ethanol in the blood, resulting in a notable reduction of hangover symptoms.

In particular, high-dose administration (500 mg/kg) led to a statistically significant decrease in blood acetaldehyde levels.

These results indicate that Euglena powder may help alleviate hangover symptoms.

◆ Paramylon

▶Immune-enhancing Effects 


· Increased macrophage activation and cytokine production following phagocytosis

· Confirmed immune-modulating effects of Euglena-derived paramylon

◆ Exosome 

▶Wrinkle Improvement Efficacy of Euglena-Derived Exosomes


Euglena-derived exosome ingredients can be safely used at concentrations below 2% without cytotoxicity. In the dermal layer of the skin, they were shown to increase the expression of the collagen-related gene ColA1 by up to 150%.

These results scientifically confirm that wrinkle improvement is mediated through collagen synthesis induction.

▶Skin Regeneration Efficacy of Euglena-Derived Exosomes


Euglena-derived exosomes can be safely used at concentrations of 1–5%, and their wound-healing effects were found to increase in a dose-dependent manner.

Furthermore, rapid skin regeneration was visually observed within 24 hours, confirming the ingredient’s cell safety and efficacy in promoting wound recovery and overall skin regeneration.

Tel. +82-70-8831-9008│Fax. +82-70-8650-9888

E-mail. contact@euealbt.com

Head Office 

511, 125 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, 28161, Republic of Korea

Seoul Branch & Research Center  

3F, 269 Donggyo-ro, Mapo-gu, Seoul, 03980, Republic of Korea

Secondary Research Center 

Room 305, Research Laboratory Building, Seoul Bio Hub, 117-3 Hoegi-ro, Dongdaemun-gu, Seoul, 02455, Republic of Korea

Factory 

7 Seongsui-ro 7-gil, Seongdong-gu, Seoul, 04781, Republic of Korea

© 2025 EUEAL BIOTECH

Head Office

511, 125 Osongsaengmyeong 2-ro, Osong-eup, Heungdeok-gu, Cheongju-si, Chungcheongbuk-do, 28161, Republic of Korea

Seoul Branch & Research Center  

3F, 269 Donggyo-ro, Mapo-gu, Seoul, 03980, Republic of Korea

Secondary Research Center  

Room 305, Research Laboratory Building, Seoul Bio Hub, 117-3 Hoegi-ro, Dongdaemun-gu, Seoul, 02455, Republic of Korea

Factory

7 Seongsui-ro 7-gil, Seongdong-gu, Seoul, 04781, Republic of Korea

© 2025 EUEAL BIOTECH